Short note answer 5 marks mbbs on decorticate and decrebrate rigidity
decorticate decerebrate rigidity MBBS neurology short note
| Feature | Decorticate | Decerebrate |
|---|---|---|
| Lesion level | Above red nucleus (rostral midbrain/forebrain) | At/below red nucleus (lower midbrain-upper pons) |
| Arms | Flexed, adducted | Extended, pronated |
| Legs | Extended | Extended |
| Prognosis | Serious but less severe | More ominous |
| Mechanism | Rubrospinal tract intact | Rubrospinal also disrupted |


Stages i Of spinal shock
stages of spinal shock Ditunno 4 phases MBBS neurology
https://www.ncbi.nlm.nih.gov/books/NBK448163
https://en.wikipedia.org/wiki/Spinal_shock
| Phase | Timing | Examination Finding | Underlying Mechanism |
|---|---|---|---|
| Phase 1 | 0-1 day | Areflexia / Hyporeflexia | Loss of descending facilitation |
| Phase 2 | 1-3 days | Initial reflex return (polysynaptic first) | Denervation supersensitivity (↑ receptor expression) |
| Phase 3 | 1-4 weeks | Initial hyperreflexia | Axon-supported synapse growth (shorter axons, interneurons) |
| Phase 4 | 1-12 months | Hyperreflexia + Spasticity | Soma-supported synapse growth (longer axons, growth factors) |
Classical decerevrate and ischemic rigidity
classical decerebrate rigidity vs ischemic rigidity alpha rigidity gamma rigidity difference physiology
classical decerebrate rigidity ischemic rigidity Sherrington gamma loop alpha rigidity dorsal root section physiology
| Pathway | Origin | Effect on Extensors |
|---|---|---|
| Pontine reticulospinal tract | Pons | Excitatory (++) |
| Lateral vestibulospinal tract (Deiters' nucleus) | Lateral vestibular nucleus | Excitatory (++) |
| Medullary reticulospinal tract | Medullary RF | Inhibitory (--) |
| Corticospinal, Rubrospinal, Corticoreticular | Cortex / Red nucleus | Drive inhibitory medullary RF |

| Feature | Detail |
|---|---|
| Lesion site | Intercollicular (between superior and inferior colliculi) |
| Antigravity muscles | Affected - neck, trunk, limb extensors |
| Abolished by | Dorsal root section, deafferentation |
| Dependent on | Gamma loop (γ → Ia spindle → α) |
| Inhibitory RF | Nonfunctional (lost cortical/rubral drive) |
| Type | Gamma (γ) rigidity |
| Feature | Detail |
|---|---|
| Lesion | Anterior cerebellar lobe removal / global brainstem ischemia |
| Mechanism | Direct α-motor neuron activation (independent of spindle) |
| Abolished by | Dorsal root section does NOT abolish it |
| Dependent on | Direct drive to α-motor neurons |
| Vestibular nuclei | Greatly hyperexcited |
| Type | Alpha (α) rigidity |
| Feature | Classical Decerebrate Rigidity | Ischemic (Alpha) Rigidity |
|---|---|---|
| Also called | Gamma rigidity | Alpha rigidity / Decerebellate rigidity |
| Transection level | Intercollicular (mid-collicular) | Intercollicular + anterior cerebellar lobe removed (or global ischemia) |
| Mechanism | γ-motor neuron → Ia spindle afferent → α-motor neuron (gamma loop) | Direct α-motor neuron activation |
| Dorsal root section | Abolishes rigidity | Does NOT abolish rigidity |
| Severity | Less severe | More severe (exaggerated rigidity) |
| Cerebellar influence | Anterior lobe intact (inhibits fastigial → partially dampens rigidity) | Anterior lobe removed → fastigial disinhibited → Deiters' nucleus hyperactive |
| Clinical correlate | Intercollicular lesions, uncal herniation | Global anoxia, severe ischemia, phenytoin toxicity (rare) |
"Gamma - Gone with dorsal root section" (classical decerebrate - gamma rigidity is abolished by cutting dorsal roots) "Alpha - Always stays" (ischemic/alpha rigidity persists even after dorsal root section)
Ans for 5 marks
professional qualities roles of a physician MBBS medical professionalism empathy patient encounters 5 marks
https://abimfoundation.org/wp-content/uploads/2015/12/Medica…
| Role | Description |
|---|---|
| Medical Expert | Core role - applying clinical knowledge and skills to patient care |
| Communicator | Effective communication with patients, families, and team |
| Collaborator | Working within health teams |
| Leader/Manager | Resource allocation, managing healthcare delivery |
| Health Advocate | Promoting patient and community health |
| Scholar | Lifelong learning, teaching, research |
| Professional | Ethical, accountable practice |
Empathy is NOT the same as sympathy.
- Sympathy = sharing the feeling ("I feel sad too")
- Empathy = understanding the feeling ("I understand how difficult this must be for you")
Moleculer motors
molecular motors kinesin dynein myosin MBBS biochemistry cell biology
| Superfamily | Track | Direction | Primary Function |
|---|---|---|---|
| Kinesin | Microtubules | Minus → Plus (anterograde) | Intracellular transport, mitosis |
| Dynein | Microtubules | Plus → Minus (retrograde) | Retrograde transport, cilia, flagella |
| Myosin | Actin filaments | Toward (+) barbed end | Muscle contraction, cell motility |

| Feature | Kinesin | Dynein | Myosin |
|---|---|---|---|
| Track | Microtubule | Microtubule | Actin filament |
| Direction | Anterograde (+ end) | Retrograde (- end) | Toward barbed (+) end |
| Size | ~100 kDa | Large complex | Varies (230 kDa heavy chain) |
| Energy source | ATP | ATP | ATP |
| Key role | Axonal anterograde transport | Retrograde transport; cilia/flagella | Muscle contraction; cell motility |
| Found in | Neurons, dividing cells | Cilia, neurons, all cells | Muscle, all cells |
| Disease | Motor Involved | Mechanism |
|---|---|---|
| Kartagener syndrome (Primary Ciliary Dyskinesia) | Axonemal dynein (absent dynein arms) | Immotile cilia → bronchiectasis, situs inversus, male infertility |
| Charcot-Marie-Tooth disease | Kinesin (KIF1B mutation) | Impaired axonal transport |
| Alzheimer's disease | Kinesin/Dynein | Disrupted axonal transport → amyloid accumulation |
| Muscle myopathies | Myosin heavy chain mutations | Impaired cross-bridge cycling |
| Vitiligo/Griscelli syndrome | Myosin Va | Defective melanosome transport to keratinocytes |
Short note on gibbs donan equilibrium
Gibbs Donnan equilibrium MBBS physiology short note membrane impermeant ions
| Compartment X (e.g., plasma / inside cell) | Compartment Y (e.g., ISF / outside cell) |
|---|---|
| K⁺, Cl⁻, Prot⁻ (impermeant protein anion) | K⁺, Cl⁻ only |
| Membrane permeable to K⁺ and Cl⁻, but NOT to Prot⁻ |

[K⁺_X] + [Cl⁻_X] + [Prot⁻_X] > [K⁺_Y] + [Cl⁻_Y] Side X has more osmotically active particles
Key concept: Normal cell volume depends on the Na⁺/K⁺-ATPase doing "osmotic work" to counteract Donnan forces. NaCl acts as a functionally impermeant extracellular solute that offsets intracellular negative charges.
| Situation | Application of Gibbs-Donnan Principle |
|---|---|
| Plasma vs. Interstitial fluid | Higher cations, lower anions in plasma due to plasma proteins (albumin) |
| Plasma vs. CSF | Cl⁻ ~15% higher in CSF (blood-brain barrier keeps proteins out) |
| Resting membrane potential | Donnan forces contribute to negative intracellular potential |
| Cell volume regulation | Na-K pump counteracts Donnan-driven swelling |
| Oncotic pressure | Donnan effect adds to colloid osmotic pressure of plasma |
| Red blood cells | Chloride shift (hamburger phenomenon) - HCO₃⁻/Cl⁻ exchange maintains Donnan equilibrium |
| Capillary fluid exchange (Starling forces) | Plasma proteins create oncotic pressure partly through Donnan effect, retaining fluid in capillaries |
Difference between Na and K channels
difference between voltage gated sodium and potassium channels structure gating kinetics action potential physiology
| Feature | Voltage-gated Na⁺ Channel (Nav) | Voltage-gated K⁺ Channel (Kv) |
|---|---|---|
| Functional unit | Single large α-subunit (pseudotetramer) | Tetramer of 4 identical or similar subunits |
| α-subunit domains | 1 α-subunit with 4 homologous domains (I-IV), each containing 6 transmembrane segments (S1-S6) | Each subunit contains 6 transmembrane segments (S1-S6); 4 subunits assemble around a central pore |
| Total TM segments | 24 (4 domains × 6 segments) | 24 (4 subunits × 6 segments) |
| Auxiliary subunits | β₁ and β₂ subunits (modulate gating and expression) | β subunits (Kvβ) in some types |
| Voltage sensor | S4 segment in each domain (positively charged Arg/Lys residues) | S4 segment in each of the 4 subunits |
| Selectivity filter | DEKA motif (Asp-Glu-Lys-Ala) in the P-loops of the 4 domains - Na⁺ selective | TVGYG motif (Thr-Val-Gly-Tyr-Gly) - K⁺ selective |
| Inactivation particle | III-IV linker loop (intracellular) acts as "ball and chain" inactivation gate (h gate) | Some Kv channels have N-type inactivation ("ball and chain" from N-terminus); slow C-type inactivation also exists |
| Gene family | SCN1A-SCN11A (Nav1.1-Nav1.9) | KCNA-KCNS (Kv1-Kv12 families), >40 subtypes |

Key difference: Na⁺ channels have a fast inactivation mechanism; delayed rectifier K⁺ channels do not inactivate (or inactivate very slowly).
| Feature | Na⁺ Channel | K⁺ Channel (Delayed Rectifier) |
|---|---|---|
| Activation speed | Very fast (opens in < 1 ms after threshold) | Slow (opens after 1-5 ms delay) |
| Inactivation | Fast (closes within 1-2 ms of opening) | None (delayed rectifier) or very slow |
| Recovery from inactivation | Requires repolarization (~1-2 ms) | Simple deactivation upon repolarization |
| Hodgkin-Huxley notation | m³h (3 m-gates + 1 h-gate) | n⁴ (4 n-gates) |
| Phase | Channel | Event |
|---|---|---|
| Resting potential (-70 mV) | Both closed | Leak K⁺ channels maintain resting potential |
| Threshold (-55 mV) | Na⁺ channels begin opening | Threshold depolarization reached |
| Upstroke / Depolarization (+30 mV) | Na⁺ channels open rapidly | Na⁺ influx → rapid depolarization (Eₙₐ = +60 mV) |
| Peak (+30 mV) | Na⁺ channels inactivate; K⁺ channels open | Na⁺ inflow stops; K⁺ outflow begins |
| Repolarization | K⁺ channels open fully | K⁺ efflux → membrane repolarizes |
| After-hyperpolarization | K⁺ channels slowly close | Brief dip below resting potential |
| Refractory period | Na⁺ channels inactivated | No new AP can be generated (absolute refractory period) |
| Drug / Toxin | Na⁺ Channel | K⁺ Channel |
|---|---|---|
| Tetrodotoxin (TTX) | Blocks (extracellular pore) | No effect |
| Local anesthetics (lidocaine, bupivacaine) | Block Na⁺ channels (use-dependent) | No direct effect |
| Antiepileptics (phenytoin, lamotrigine, carbamazepine) | Block (bind to inactivated state) | No effect |
| Tetraethylammonium (TEA) | No effect | Blocks K⁺ channels |
| 4-Aminopyridine (4-AP) | No effect | Blocks voltage-gated K⁺ channels |
| Scorpion/sea anemone toxins | Delay inactivation | - |
| Class I antiarrhythmics (quinidine, flecainide) | Block Na⁺ channels | - |
| Class III antiarrhythmics (amiodarone, sotalol) | Some Na⁺ block | Block K⁺ channels (prolong repolarization) |
| Feature | Voltage-gated Na⁺ Channel | Voltage-gated K⁺ Channel |
|---|---|---|
| Ion selectivity | Na⁺ (inward current) | K⁺ (outward current) |
| Structure | 1 α-subunit, 4 domains, pseudotetramer | 4 separate subunits, true tetramer |
| Activation threshold | ~ -55 mV | ~ -40 mV (opens after Na⁺ channel) |
| Activation speed | Very fast (< 1 ms) | Slow (1-5 ms delay) |
| Inactivation | Fast (h gate, III-IV linker) | No inactivation (delayed rectifier) |
| States | 3 states: Closed / Open / Inactivated | 2 states: Closed / Open |
| Direction of ion flow | Inward (Na⁺ in) | Outward (K⁺ out) |
| Role in AP | Upstroke (depolarization) | Repolarization |
| Refractory period | Responsible for absolute RP | Contributes to relative RP |
| Selectivity filter | DEKA motif | TVGYG motif |
| Toxin | Blocked by TTX | Blocked by TEA / 4-AP |
| Gene | SCN family | KCNA-KCNS family |
Physiological basis of st elevation
physiological basis ST elevation current of injury ischemia ECG mechanism diastolic systolic current
https://pmc.ncbi.nlm.nih.gov/articles/PMC4116460
"Severe, acute ischemia lowers the resting membrane potential and shortens the duration of the action potential. Such changes cause a voltage gradient between normal and ischemic zones. As a consequence, current flows between those regions. These currents of injury are represented on the surface ECG by deviation of the ST segment." — Harrison's Principles of Internal Medicine 22e
| Effect | Mechanism |
|---|---|
| Resting membrane potential rises (less negative, partial depolarization) | ATP depletion → Na⁺/K⁺-ATPase fails → Na⁺ accumulates inside → K⁺ leaks out → reduced electronegativity |
| Action potential duration shortens | Ischemia accelerates repolarization (shortens Phase 2 plateau) |
| AP amplitude decreases | Reduced Na⁺ channel availability at the depolarized resting potential |
| Loss of epicardial AP dome | Ischemia particularly shortens the epicardial action potential plateau (Phase 2 dome lost) |

| Type | ST Vector Direction | ECG Appearance |
|---|---|---|
| Transmural (epicardial) ischemia | Directed outward (toward epicardium / away from cavity) | ST elevation in overlying leads; reciprocal ST depression in opposite leads |
| Subendocardial ischemia | Directed inward (toward endocardium / into cavity) | ST depression in precordial leads; ST elevation in aVR |
| Time | ECG Change | Mechanism |
|---|---|---|
| Minutes | Hyperacute T waves (tall, broad, peaked) | Earliest sign; increased T amplitude due to focal ischemia |
| Minutes-hours | ST elevation (injury current) | Transmural ischemia/injury - current of injury |
| Hours-days | T-wave inversion | Repolarization abnormality in peri-infarct zone |
| Hours-days | Pathological Q waves | Necrosis → loss of depolarization forces from infarcted tissue |
| Days-weeks | ST normalizes | Resolution of injury; Q waves and T-inversion may persist |
| Leads with ST elevation | Region of ischemia | Likely artery |
|---|---|---|
| V1-V4 | Anterior wall | LAD (Left Anterior Descending) |
| II, III, aVF | Inferior wall | RCA (Right Coronary Artery) |
| I, aVL, V5-V6 | Lateral wall | LCx (Left Circumflex) |
| V1-V3 (ST depression - "posterior equivalent") | Posterior wall | RCA / LCx |
| V1, V4R (right-sided leads) | Right ventricle | Proximal RCA |
| Feature | Hemiplegia | Paraplegia |
|---|---|---|
| Limbs affected | One side (arm + leg + face) | Both lower limbs only |
| Lesion site | Above pyramidal decussation (hemisphere / IC / upper brainstem) | Bilateral spinal cord (thoracic) or bilateral parasagittal cortex |
| Side affected | Contralateral to hemispheric lesion | Bilateral |
| Common cause | Stroke, brain tumor, head injury | Spinal cord injury, MS, tumor |

| Region | % of fibers |
|---|---|
| Primary motor cortex (Brodmann area 4) - precentral gyrus | >50% |
| Premotor and supplementary motor areas (area 6) | ~30% |
| Parietal somatosensory cortex (areas 3, 1, 2, 5, 7) | ~20% |
Walleriaj degeneration in Short guyton with flowchart
Wallerian degeneration Guyton physiology nerve injury axon degeneration regeneration steps

NERVE INJURY (axonotmesis / neurotmesis)
│
▼
┌──────────────────────────────────────────┐
│ IMMEDIATE (0-24 hrs) │
│ - Axoplasm leaks at injury site │
│ - Ca²⁺ and Na⁺ influx through │
│ disrupted axonal membrane │
│ - Axoplasmic flow interrupted │
└──────────────┬───────────────────────────┘
│
┌─────────┴──────────┐
▼ ▼
DISTAL TO INJURY PROXIMAL TO INJURY
(Wallerian / (Retrograde changes)
Anterograde
degeneration)
│ │
▼ ▼
┌─────────────────┐ ┌────────────────────┐
│ 8-24 hrs: │ │ CELL BODY: │
│ Axonal swelling │ │ CHROMATOLYSIS │
│ │ │ - Nissl bodies │
│ │ │ disperse/dissolve │
│ │ │ - Nucleus moves to │
│ │ │ cell periphery │
│ │ │ - Cell swells │
│ │ │ - Switch from │
│ │ │ maintenance to │
│ │ │ regeneration mode │
└────────┬────────┘ └────────────────────┘
│
▼
┌─────────────────────┐
│ DAY 1-3: │
│ Granular │
│ disintegration of │
│ axonal cytoskeleton │
│ - Microtubules │
│ disassemble │
│ - Neurofilaments │
│ break down │
│ - Axon fragments │
└────────┬────────────┘
│
▼
┌─────────────────────┐
│ DAY 3-7: │
│ SCHWANN CELL │
│ CHANGES │
│ - Retract from │
│ nodes of Ranvier │
│ - Dedifferentiate │
│ → Repair Schwann │
│ cells │
│ - Downregulate │
│ myelin proteins │
│ - Upregulate c-Jun │
│ - Myelin autophagy │
│ (myelin breakdown) │
└────────┬────────────┘
│
▼
┌─────────────────────┐
│ DAY 3-14: │
│ MACROPHAGE │
│ INFILTRATION │
│ - Schwann cells │
│ secrete cytokines │
│ - Macrophages │
│ recruited │
│ - Phagocytosis of │
│ axon debris + │
│ myelin fragments │
│ (myelin = "debris") │
└────────┬────────────┘
│
▼
┌─────────────────────┐
│ ~1 WEEK: │
│ BANDS OF BÜNGNER │
│ - Repair Schwann │
│ cells proliferate │
│ - Align along empty │
│ endoneurial tubes │
│ - Form hollow │
│ cellular "tubes" │
│ - Secrete NGF, BDNF, │
│ GGFs (neurotrophins│
│ guide regeneration)│
└────────┬────────────┘
│
▼
┌─────────────────────────────────────────────┐
│ REGENERATION PHASE │
│ │
│ Day 4 onwards: Proximal stump sends sprouts │
│ Growing axon cone penetrates Bands of Büngner│
│ Rate: 0.5-3 mm/day (avg ~1 mm/day) │
│ Target organ reinnervated │
│ Schwann cells redifferentiate → remyelinate │
│ New myelin = thinner, shorter internodes │
└─────────────────────────────────────────────┘
| Time | Event |
|---|---|
| 0-24 hours | Axonal swelling; Ca²⁺ influx activates proteases; loss of anterograde/retrograde transport |
| Day 1-3 | Axon fragments and disintegrates; granular disintegration of cytoskeleton (microtubules, neurofilaments break down) |
| Day 3 | Schwann cells retract from nodes of Ranvier; dedifferentiate into repair Schwann cells; myelin autophagy begins |
| Day 3-14 | Macrophages infiltrate; phagocytose axon fragments and myelin debris |
| ~1 week | Complete Wallerian degeneration of distal stump; endoneurial tubes emptied |
| 1-2 weeks | Proliferating repair Schwann cells form Bands of Büngner (linear columns inside endoneurial tubes) |
| Feature | PNS | CNS |
|---|---|---|
| Supporting cells | Schwann cells → dedifferentiate, support regeneration | Oligodendrocytes → undergo apoptosis after axon loss |
| Debris clearance | Efficient (macrophages + repair Schwann cells) | Inefficient (microglia, astrocytes fail to clear myelin) |
| Myelin inhibitors | Absent | Myelin-associated glycoprotein (MAG), Nogo-A inhibit axon growth |
| Tubes | Endoneurial tubes guide growth | No such guiding structure |
| Neurotrophins | Secreted by repair Schwann cells | Limited production |
| Result | Regeneration possible | No functional regeneration |
| Aspect | Detail |
|---|---|
| Denervation atrophy | Muscle supplied by injured nerve atrophies (seen from ~3 weeks); irreversible after ~1-2 years if reinnervation doesn't occur |
| Nerve conduction studies | Distal CMAP amplitude drops after day 3-5 (Wallerian degeneration complete); useful to differentiate neurapraxia from axonotmesis |
| Tinel's sign | Tingling on percussion over regenerating nerve tip - tracks progression of regeneration |
| Rate of recovery | Can calculate expected recovery time = distance from injury to target muscle ÷ 1 mm/day |
| Surgical repair | End-to-end or graft repair within 6-12 months for best outcome before target organs become refractory |